复星医药公告,公司将于2025年6月24日召开2024年度股东会、2025年第一次A股类别股东会及2025年第一次H股类别股东会。会议将审议包括2024年年度报告、利润分配预案、董事选举等多项议案,并涉及特别决议事项。A股股东可通过现场或网络投票参与,H股股东需参阅香港联交所发布的相关文件。参会股东需在2025年6月18日前完成股权登记。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.